Evidence map›Paper›PMID 30420769›Full record

ArticleScientific reports2018

Cyclosporine A binding to COX-2 reveals a novel signaling pathway that activates the IRE1α unfolded protein response sensor.

Jody Groenendyk, Tautvydas Paskevicius, Hery Urra, Clement Viricel, Kui Wang, Khaled Barakat, Claudio Hetz, Lukasz Kurgan, Luis B Agellon, Marek Michalak

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Two pools of IRE1α in cardiac and skeletal muscle cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 5 countries.

Jody GroenendykDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, T6G 2S7, Canada.
Tautvydas PaskeviciusDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, T6G 2S7, Canada.
Hery UrraBiomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Santiago, Chile.
Clement ViricelFaculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, T6G 2S7, Canada.
Kui WangSchool of Mathematical Sciences and LPMC, Nankai University, Tianjin, People's Republic of China.
Khaled BarakatFaculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, T6G 2S7, Canada.
Claudio HetzBiomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Santiago, Chile.ORCID http://orcid.org/0000-0001-7724-1767
Lukasz KurganDepartment of Computer Science, Virginia Commonwealth University, Richmond, 23284, USA.
Luis B AgellonSchool of Human Nutrition, McGill University, Ste. Anne de Bellevue, Quebec, H9X 3V9, Canada. luis.agellon@mcgill.ca.
Marek MichalakDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, T6G 2S7, Canada. marek.michalak@ualberta.ca.
University of Alberta · CABuck Institute for Research on Aging · USCenter for Climate and Resilience Research · CLMcGill University · CANankai University · CNVirginia Commonwealth University · US

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 152911Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 15415Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 53050Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 86750
6 · The paper itself

Abstract

Cyclosporine, a widely used immunosuppressant in organ transplantation and in treatment of various autoimmune diseases, activates the unfolded protein response (UPR), an ER stress coping response. In this study we discovered a new and unanticipated cyclosporine-dependent signaling pathway, with cyclosporine triggering direct activation of the UPR. COX-2 binds to and activates IRE1α, leading to IRE1α splicing of XBP1 mRNA. Molecular interaction and modeling analyses identified a novel interaction site for cyclosporine with COX-2 which caused enhancement of COX-2 enzymatic activity required for activation of the IRE1α branch of the UPR. Cyclosporine-dependent activation of COX-2 and IRE1α in mice indicated that cyclosporine-COX-2-IRE1α signaling pathway was functional in vivo. These findings identify COX-2 as a new IRE1α binding partner and regulator of the IRE1α branch of the UPR pathway, and establishes the mechanism underlying cytotoxicity associated with chronic cyclosporine exposure.

Indexed as

AnimalsCyclooxygenase 2CyclosporineEndoribonucleasesHEK293 CellsHumansImmunoprecipitationMaleMiceMolecular Dynamics SimulationProtein BindingProtein Serine-Threonine KinasesProtein Structure, TertiarySignal TransductionUnfolded Protein ResponseCyclooxygenase 2CyclosporineEndoribonucleasesERN1 protein, humanProtein Serine-Threonine Kinases

Identifiers

PMID30420769
PMCPMC6232179
OpenAlexW2899680415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.